Annual D&A
$192.80M$400.00K+0.21%
Summary
- Current Value
- As of today, BIO annual D&A is $192.80M, up +0.21% on
- Historical Performance
- BIO annual D&A is up +8.99% over the past 3 years, and up +10.49% over the past 5 years
- All-Time High Comparison
- BIO annual D&A is currently at its all-time high
- 3-Year Low Comparison
- BIO annual D&A is +8.80% above its 3-year low of $177.20M reached on an earlier date
- Sector Comparison
- BIO annual D&A is higher than 91.62% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $192.80M | +0.2% | +9.0% | +10.5% | +89.6% | |
| Quarterly D&A | $54.20M | +10.4% | +22.9% | +27.2% | +105.8% | |
| TTM D&A | $202.30M | +3.0% | +12.9% | +16.8% | +87.9% | |
| Price | $325.50 | -5.2% | -22.3% | -46.8% | +208.5% | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $4.41B | +33.3% | +431.2% | +697.6% | +169.0% | |
| Annual Operating Expenses | $1.07B | +1.9% | -2.8% | +6.0% | +39.6% | |
| Annual Revenue | $2.57B | -3.9% | -12.2% | +11.0% | +43.8% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $192.80M | at high | |
| 5Y | $192.80M | at high | |
| All | $192.80M | at high |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $177.20M | N/A | +8.8% |
| 5Y | $175.20M | N/A | +10.1% |
| All | $1.15M | >+9999.0% |
Depreciation & Amortization History
FAQ
What is the current annual D&A of BIO?
As of today, BIO annual D&A is $192.80M
What is 1-year change in BIO annual D&A?
BIO annual D&A is up +0.21% year-over-year
What is 3-year change in BIO annual D&A?
BIO annual D&A is up +8.99% over the past 3 years
How far is BIO annual D&A from its all-time high?
BIO annual D&A is currently at its all-time high
How does BIO annual D&A rank versus sector peers?
BIO annual D&A is higher than 91.62% of companies in Healthcare sector
When is BIO next annual earnings release?
The next annual earnings release for BIO is on
Quarterly D&A
$54.20M$3.60M+7.11%
Summary
- Current Value
- As of today, BIO quarterly D&A is $54.20M, up +7.11% on
- Historical Performance
- BIO quarterly D&A is up +10.39% year-over-year, and up +22.90% over the past 3 years
- All-Time High Comparison
- BIO quarterly D&A is currently at its all-time high
- 3-Year Low Comparison
- BIO quarterly D&A is +18.86% above its 3-year low of $45.60M reached on
- Sector Comparison
- BIO quarterly D&A is higher than 91.05% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $54.20M | +7.1% | +10.4% | +22.9% | +27.2% | |
| Annual D&A | $192.80M | – | +0.2% | +9.0% | +10.5% | |
| TTM D&A | $202.30M | +2.6% | +3.0% | +12.9% | +16.8% | |
| Price | $325.50 | +5.3% | -5.2% | -22.3% | -46.8% | |
| Quarterly SG&A | $206.80M | -0.4% | +3.2% | -2.0% | +4.4% | |
| Quarterly Total Expenses | $994.90M | +198.1% | +10000.0% | +17.9% | +249.0% | |
| Quarterly Operating Expenses | $276.40M | +4.0% | +5.7% | -0.8% | +7.2% | |
| Quarterly Revenue | $653.00M | +0.2% | +0.5% | -4.1% | +0.9% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $54.20M | at high | |
| 3Y | $54.20M | at high | |
| 5Y | $54.20M | at high | |
| All | $54.20M | at high |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $48.20M | +12.4% | |
| 3Y | $45.60M | +18.9% | |
| 5Y | $42.50M | +27.5% | |
| All | $2.30M | +2256.5% |
Quarterly D&A History
FAQ
What is the current quarterly D&A of BIO?
As of today, BIO quarterly D&A is $54.20M
What is BIO quarterly D&A most recent change?
BIO quarterly D&A was up +7.11% on September 30, 2025
What is 1-year change in BIO quarterly D&A?
BIO quarterly D&A is up +10.39% year-over-year
How far is BIO quarterly D&A from its all-time high?
BIO quarterly D&A is currently at its all-time high
How does BIO quarterly D&A rank versus sector peers?
BIO quarterly D&A is higher than 91.05% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
TTM D&A
$202.30M$5.10M+2.59%
Summary
- Current Value
- As of today, BIO TTM D&A is $202.30M, up +2.59% on
- Historical Performance
- BIO TTM D&A is up +2.95% year-over-year, and up +12.95% over the past 3 years
- All-Time High Comparison
- BIO TTM D&A is currently at its all-time high
- 3-Year Low Comparison
- BIO TTM D&A is +14.16% above its 3-year low of $177.20M reached on an earlier date
- Sector Comparison
- BIO TTM D&A is higher than 91.15% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $202.30M | +2.6% | +3.0% | +12.9% | +16.8% | |
| Annual D&A | $192.80M | – | +0.2% | +9.0% | +10.5% | |
| Quarterly D&A | $54.20M | +7.1% | +10.4% | +22.9% | +27.2% | |
| Price | $325.50 | +5.3% | -5.2% | -22.3% | -46.8% | |
| TTM SG&A | $30.15B | +3572.8% | +3589.6% | +3490.7% | +3691.3% | |
| TTM Revenue | $2.56B | +0.1% | -0.9% | -8.8% | +7.5% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $202.30M | at high | |
| 3Y | $202.30M | at high | |
| 5Y | $202.30M | at high | |
| All | $202.30M | at high |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $192.80M | N/A | +4.9% |
| 3Y | $177.20M | N/A | +14.2% |
| 5Y | $174.20M | +16.1% | |
| All | $2.30M | +8695.6% |
TTM D&A History
FAQ
What is the current TTM D&A of BIO?
As of today, BIO TTM D&A is $202.30M
What is BIO TTM D&A most recent change?
BIO TTM D&A was up +2.59% on September 30, 2025
What is 1-year change in BIO TTM D&A?
BIO TTM D&A is up +2.95% year-over-year
How far is BIO TTM D&A from its all-time high?
BIO TTM D&A is currently at its all-time high
How does BIO TTM D&A rank versus sector peers?
BIO TTM D&A is higher than 91.15% of companies in Healthcare sector
When is BIO next earnings release?
The next earnings release for BIO is on
Data Sources & References
- BIO Official Website www.bio-rad.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/12208/000001220825000077/0000012208-25-000077-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/12208/000001220825000007/0000012208-25-000007-index.htm
- BIO Profile on Yahoo Finance finance.yahoo.com/quote/BIO
- BIO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bio